The_DT
Epstein-Barr_JJ
virus_NN
latency_NN
BamHI-Q_NN
promoter_NN
is_VBZ
positively_RB
regulated_VBN
by_IN
STATs_NNS
and_CC
Zta_NN
interference_NN
with_IN
JAK\/STAT_NN
activation_NN
leads_VBZ
to_TO
loss_NN
of_IN
BamHI-Q_NN
promoter_NN
activity_NN
._.

In_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
-_:
associated_VBN
tumors_NNS
in_IN
nonimmunocompromised_JJ
patients_NNS
,_,
EBV_NN
gene_NN
expression_NN
is_VBZ
highly_RB
restricted_JJ
._.

EBV-encoded_JJ
nuclear_JJ
antigen_NN
-LRB-_-LRB-
EBNA_NN
-RRB-_-RRB-
-1_CD
is_VBZ
expressed_VBN
,_,
whereas_IN
the_DT
immunogenic_JJ
and_CC
proliferative_JJ
EBNAs_NNS
are_VBP
not_RB
._.

This_DT
pattern_NN
of_IN
EBNA_NN
expression_NN
is_VBZ
generated_VBN
by_IN
usage_NN
of_IN
the_DT
BamHI-Q_NN
promoter_NN
-LRB-_-LRB-
Qp_NN
-RRB-_-RRB-
._.

We_PRP
have_VBP
determined_VBN
that_IN
the_DT
JAK\/STAT_JJ
pathway_NN
positively_RB
regulates_VBZ
Qp_NN
activity_NN
._.

In_IN
transient-transfection_JJ
assays_NNS
,_,
a_DT
Qp-CAT_NN
reporter_NN
was_VBD
activated_VBN
by_IN
cotransfected_VBN
JAK-1_NN
and_CC
by_IN
treatment_NN
of_IN
cells_NNS
with_IN
the_DT
cytokine_NN
IL-6_NN
._.

The_DT
ability_NN
of_IN
Qp_NN
to_TO
bind_VB
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
proteins_NNS
was_VBD
directly_RB
demonstrated_VBN
by_IN
electrophoretic_JJ
mobility-shift_JJ
assay_NN
,_,
and_CC
mutation_NN
of_IN
potential_JJ
STAT-binding_JJ
sites_NNS
reduced_VBD
Qp_NN
responsiveness_NN
to_TO
Janus_NN
kinase_NN
-LRB-_-LRB-
JAK_NN
-RRB-_-RRB-
-1_CD
._.

Consistent_JJ
with_IN
a_DT
role_NN
for_IN
STATs_NNS
in_IN
Qp_NN
function_NN
,_,
Qp_NN
using_VBG
Burkitt_NN
's_POS
lymphoma_NN
Rael_NN
cells_NNS
and_CC
cultured_VBN
nasopharyngeal_JJ
carcinoma_NN
-LRB-_-LRB-
NPC_NN
-RRB-_-RRB-
cells_NNS
contained_VBD
nuclear_JJ
STAT_NN
protein_NN
._.

We_PRP
investigated_VBD
whether_IN
the_DT
inability_NN
to_TO
maintain_VB
EBV-positive_JJ
NPC_NN
cell_NN
lines_NNS
in_IN
culture_NN
was_VBD
related_JJ
to_TO
Qp_NN
activity_NN
._.

Passaging_NN
of_IN
the_DT
NPC_NN
cell_NN
line_NN
HK666_NN
led_VBD
to_TO
activation_NN
of_IN
expression_NN
of_IN
BZLF1_NN
,_,
which_WDT
encodes_VBZ
Zta_NN
and_CC
loss_NN
of_IN
Qp_NN
function_NN
._.

Transient_JJ
expression_NN
assays_NNS
linked_VBD
Zta_NN
expression_NN
to_TO
the_DT
down-regulation_NN
of_IN
Qp_NN
._.

Cotransfection_NN
of_IN
Zta_NN
reduced_VBD
Qp_NN
activity_NN
in_IN
reporter_NN
assays_NNS
._.

This_DT
negative_JJ
regulation_NN
required_VBD
Zta_NN
DNA-binding_JJ
activity_NN
._.

We_PRP
provide_VBP
evidence_NN
that_IN
Zta_NN
up-regulation_NN
of_IN
p53_NN
leads_VBZ
to_TO
p53-mediated_JJ
interference_NN
with_IN
JAK\/STAT_JJ
activation_NN
of_IN
Qp_NN
._.

The_DT
data_NNS
imply_VBP
that_IN
JAK\/STAT_NN
signaling_NN
has_VBZ
a_DT
role_NN
in_IN
EBV-associated_JJ
malignancies_NNS
._.

